Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07680894 · ClinicalTrials.gov registry record · NA

DockTales for Chronic Pain

A NA study, sponsored by University of Maryland, Baltimore.

Not yet
Registry status
NA
Development phase
60
Enrollment target

NCT07680894: Clinical Trial NA study, sponsored by University of Maryland, Baltimore.

NCT07680894 is a NA study that has not yet begun recruiting, run by University of Maryland, Baltimore. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07680894, a NA study, has not yet begun recruiting, sponsored by University of Maryland, Baltimore.

NOT YET RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

This study will evaluate the feasibility and acceptability of DockTales, a mobile health tool designed for adults with chronic pain. DockTales supports pain and sleep tracking through brief diaries, body-map pain reporting, reflective journaling, visual summaries, and optional AI-supported interaction. The study will be conducted completely remotely. Participants will complete 2 weeks of DockTales use and 2 weeks of REDCap-based daily monitoring, with the order randomized. The main goal is to determine whether DockTales is usable, acceptable, engaging, and practical for adults with chronic pain compared with standard REDCap monitoring.

Primary Outcome

Enrollment rate: the proportion (%) of recruited participants who enrolled in the study.

Interventions

  • BEHAVIORAL DockTales
  • OTHER REDCap monitoring

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2026-07-17
Est. Completion 2027-10-24
Phase NA
University of Maryland, Baltimore

560 total trials

What is known before NCT07680894 opens enrollment

NCT07680894 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which DockTales is the first listed.

NCT07680894 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07680894 about?

NCT07680894 is a clinical study titled "DockTales for Chronic Pain". This study will evaluate the feasibility and acceptability of DockTales, a mobile health tool designed for adults with chronic pain. DockTales supports pain and sleep tracking through brief diaries, body-map pain reporting, reflective journaling, visual summaries, and optional AI-supported interacti...

What is the current status of trial NCT07680894?

This trial is currently not yet recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2026-07-17. Estimated completion is 2027-10-24.

What interventions are being tested in trial NCT07680894?

The interventions under investigation include: DockTales (BEHAVIORAL), REDCap monitoring (OTHER).

Who is sponsoring clinical trial NCT07680894?

This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07680894's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07680894, the US trial registry maintained by the National Library of Medicine. NCT07680894 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.